US2020299767A1PendingUtilityA1
Compositions and methods for accurately identifying mutations
Assignee: HUTCHINSON FRED CANCER RESPriority: Feb 17, 2012Filed: Jun 10, 2020Published: Sep 24, 2020
Est. expiryFeb 17, 2032(~5.6 yrs left)· nominal 20-yr term from priority
Inventors:Jason H. Bielas
C12N 15/10C12Q 1/6869C12Q 1/6874C12N 15/81C40B 50/06C12N 15/85C40B 40/08C12N 15/1093C12N 15/1065C12Q 1/6827C12N 15/70Y02E50/10
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides compositions and methods for accurately detecting mutations by uniquely tagging double stranded nucleic acid molecules with dual cyphers such that sequence data obtained from a sense strand can be linked to sequence data obtained from an anti-sense strand when sequenced, for example, by massively parallel sequencing methods.
Claims
exact text as granted — not AI-modified1 .- 38 . (canceled)
39 . A method for reducing an error rate in sequence reads of a double-stranded target nucleic acid molecule, comprising:
a) ligating the double-stranded target nucleic acid molecule to a double-stranded cypher to form a cypher-target nucleic acid complex, wherein the double-stranded cypher comprises a random or partially random identifier sequence that alone or in combination with an end of the target nucleic acid molecule uniquely labels the double-stranded target nucleic acid molecule; b) amplifying each strand of the cypher-target nucleic acid complex to produce a plurality of cypher-target amplification products from each of a first strand and a complementary second strand of the cypher-target nucleic acid complex; (c) sequencing the cypher-target amplification products to produce a plurality of first-strand sequencing reads and a plurality of second-strand sequencing reads; and (d) comparing the first-strand sequencing reads with the second-strand sequencing reads, and generating an error-corrected sequence of the double-stranded target nucleic acid molecule by distinguishing erroneous nucleotides in one strand that lack a matched base change in the complementary strand.
40 . The method of claim 39 , wherein the double-stranded target nucleic acid molecule comprises (i) a DNA molecule, (ii) an RNA molecule, or (iii) a cDNA molecule derived from an RNA molecule.
41 . The method of claim 39 , wherein the cypher-target nucleic acid complex comprises at least two nucleic acid molecule priming sites.
42 . The method of claim 39 , wherein the cypher-target nucleic acid complex comprises an identifier sequence on both strands.
43 . The method of claim 39 , wherein the cypher-target nucleic acid complex comprises an identifier sequence at each end.
44 . The method of claim 42 , wherein the random or partially-random identifier sequence is double-stranded.
45 . The method of claim 44 , wherein the random or partially-random identifier sequence comprises about 5 to about 20 nucleotides.
46 . The method of claim 39 , wherein the random or partially-random identifier sequence uniquely labels the double-stranded target nucleic acid molecule.
47 . The method of claim 39 , wherein the double-stranded cypher uniquely links each strand of the double-stranded target nucleic acid molecule relative to its original complementary strand.
48 . The method of claim 39 , wherein the target nucleic acid molecule is ligated to a distinct cypher on each end, thereby providing a unique pair of identifiers for the target nucleic acid molecule.
49 . The method of claim 39 , wherein a unique pair of identifiers is provided for each target nucleic acid molecule in a plurality of target nucleic acid molecules in the ligating step.Join the waitlist — get patent alerts
Track US2020299767A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.